Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

20011,464 citationsJournal Articlebronze Open Access

Authors

Juhani Eskola · Institute for Molecular Medicine Finland

Terhi Kilpi · Institute for Molecular Medicine Finland

Arto A. Palmu · Institute for Molecular Medicine Finland

Jukka Jokinen · Institute for Molecular Medicine Finland

Mervi Eerola

Jaason Haapakoski · Institute for Molecular Medicine Finland

Elja Herva · Institute for Molecular Medicine Finland

Abstract

The heptavalent pneumococcal polysaccharide-CRM197 conjugate vaccine is safe and efficacious in the prevention of acute otitis media caused by the serotypes included in the vaccine.

Topics & Keywords

Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 344, Issue 6, pp. 403-409

DOI: 10.1056/nejm200102083440602

Field-Weighted Citation Impact: 83.14